The growing demand for controlled immunological study and therapeutic development has spurred significant advances in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique functional roles, are frequently manufactured using various expression platforms, including prokaryotic hosts, animal cell cultures, and viral tra